热景生物拟分别增资舜景医药、尧景基因

Group 1 - The company plans to increase its investment in Beijing ShunJing Biopharmaceutical Technology Co., Ltd. by 371 million yuan at a price of 26.5 yuan per registered capital, acquiring 400,000 shares from Lishui Qiaoda Venture Capital Partnership [1] - Following the investment and share acquisition, the company's ownership in ShunJing Biopharmaceutical will rise from 43.1842% to 50.234%, making it a controlling subsidiary [1] - The company intends to implement a stock incentive plan to motivate the core team and key personnel of ShunJing Biopharmaceutical, with an additional investment of 40 million yuan at a price of 10 yuan per registered capital [1] Group 2 - The company announces a capital increase in Beijing YaoJing Gene Technology Co., Ltd. totaling 80 million yuan, with contributions from the company, Lin Changqing, and YaoJing Partnership [2] - The company will invest 24 million yuan, while Lin Changqing will contribute 50 million yuan, and YaoJing Partnership will invest 6 million yuan at a price of 2 yuan per registered capital [2] - After the capital increase, the company's ownership in YaoJing Gene will decrease from 40.91% to 38% [2]